From the EV space today…
Volkswagen on Tuesday announced plans to invest 180 billion euros ($192.6 billion) between 2023 and 2027, with more than two thirds targeting “electrification and digitalization.”
The German automotive giant earlier this month posted a full-year 2022 operating profit of 22.5 billion euros, up 13% from the previous year, with battery and electric vehicle (BEV) deliveries rising 26%.
Click here to read more.
Across Markets…
Australian shares rose 0.9 per cent by 60 points to 7068.9, led by gains in the technology sector.
Afterpay parent Block Inc shares were up 3.9 per cent to $108.40 per share.
Accounting software Xero shares were up 4 per cent to $88.47 per share.
BHP Group shares increased 1.2 per cent to $45.56 per share.
The major banks were in the green. Commonwealth Bank shares were up 0.1 per cent, Westpac shares rose 1.1 per cent. National Bank of Australia shares were up 0.8 per cent. Australia and New Zealand Bank shares increased 1.1 per cent.
Bond yields globally recovered some lost ground after closely watched US inflation figures reinforced bets of a small interest rate increase by the Federal Reserve at its meeting next week.
In Australia, bond futures imply the Reserve Bank will keep the cash rate on hold at 3.6 per cent until mid-next year. Last week, they had wagered the central bank would lift interest rates at least twice, but the collapse of Silicon Valley Bank triggered a reset of interest rate expectations everywhere.
US Treasury two-year yields bounced 26 basis points to 4.3 per cent and the 10-year rate gained 12 basis points to 3.68 per cent. Wall Street rebounded as traders speculated that the worst of the sell-off was over.
Source: AFR
Incannex Healthcare (ASX: IHL) has emerged from a trading halt with news that its psychotherapy program to treat generalised anxiety disorder (GAD) has achieved promising results in an ongoing phase two clinical trial.
The cannabinoid and psychedelic medicines company’s proprietary program is being developed to use psilocybin to improve the effectiveness of psychotherapy for GAD.
A review of interim data from the first 29 participants to complete the treatment protocol has indicated a high probability (greater than 85%) that the total study will show a “statistically significant benefit” for the psilocybin treatment arm over the placebo treatment arm.
A review was also conducted by an independent Data Safety Monitoring Board (DSMB), which identified no safety concerns to date and recommended no adjustments to the original study design or sample size.
Source: SmallCaps
Sector: Uranium
Deal Type: IPO
Raise Amount: $7.5M
Latest Entry Price: $0.20
Today’s Price Change: $0.28 -6.67%
Company: Unith Ltd. (ASX:UNT)
Sector: AI/ChatGPT
Deal Type: Placement
Raise Amount: $4.5M
Latest Entry Price: $0.033 with a 1:1 UNTO
Today’s Price Change: $0.032 +10.34%
Company: Volt Resources Ltd. (ASX:VRC)
Sector: Battery Metals
Deal Type: Placement
Raise Amount: $5.75M
Latest Entry Price: $0.011
Today’s Price Change: $0.011 Unchanged
Company: Castle Minerals Ltd. (ASX:CDT)
Sector: Battery Metals/Base Metals
Deal Type: Placement
Raise Amount: $1.52M
Latest Entry Price: $0.03 with a 1:3 CDTOA
Today’s Price Change: $0.021 Unchanged
Company: Avenira Ltd. (ASX:AEV)
Sector: Phosphate
Deal Type: Placement
Raise Amount: $2.1M
Latest Entry Price: $0.01 with a 1:2 Listed Option
Today’s Price Change: $0.012 Unchanged
Company: Latrobe Magnesium Ltd. (ASX:LMG)
Sector: Magnesium
Deal Type: Placement
Raise Amount: $3M & $11.5M
Latest Entry Price: $0.10 with a 1:4 LMGO
Today’s Price Change: $0.066 +3.13%
Company: Askari Metals Ltd (ASX:AS2)
Sector: Mining
Deal Type: IPO
Raise Amount: $5.7M
Latest Entry Price: $0.35 with a 1:3 AS2O
Today’s Price Change: $0.505 +1.00%
Company: Tymlez Ltd (ASX:TYM)
Sector: Blockchain
Deal Type: IPO/On-market purchase
Raise Amount: $13.3M
Latest Entry Price: $0.01
Today’s Price Change: $0.014 Unchanged
Company: iCandy (ASX:ICI)
Sector: Gaming & Digital Advertising
Deal Type: Placement
Raise Amount: $1.25M
Latest Entry Price: $0.02 with a 1:1 ICIOB
Today’s Price Change: $0.048 +2.13%
Sector: Fintech
Deal Type: Placement
Raise Amount: $1.5M
Latest Entry Price: $0.015 with a 1:2 FFGOA
Today’s Price Change: $0.016 Unchanged
Company: Lobe Sciences (CSE:LOBE)
Sector: Medtech
Deal Type: Pre-IPO
Raise Amount: $1.5M
Latest Entry Price: $0.05 with a 1:1 Warrants
Today’s Price Change: $0.035 -12.50%
Company: Paradigm Biopharma (ASX:PAR)
Sector: Biopharma
Deal Type: IPO Cornerstone
Raise Amount: $1M+
Latest Entry Price: $0.35
Today’s Price Change: $1.37 Unchanged
Company: ReNu Energy Limited (ASX:RNE)
Sector: Energy
Deal Type: Placement
Raise Amount: $1.46M
Latest Entry Price: $0.06 with a 1:1 RNEO
Today’s Price Change: $0.047 Unchanged
Company: Cipherpoint Limited (ASX:CPT)
Sector: Cybersecurity
Deal Type: Placement
Raise Amount: $2.9M
Latest Entry Price: $0.005 with a 1:1 Listed Option
Today’s Price Change: $0.006 -14.29%
Company: Metals Australia Limited (ASX:MLS)
Sector: Lithium/Graphite
Deal Type: Placement
Raise Amount: $7.8M
Latest Entry Price: $0.078 with 1:1 MLSOD
Today’s Price Change: $0.042 +2.44%
Company: BBX Minerals Ltd (ASX:BBX)
Sector: Mining
Deal Type: Placement
Raise Amount: $2.1M
Latest Entry Price: $0.082 with a 1:1 BBXOA
Today’s Price Change: $0.12 +4.35%
Sector: CBD
Raise Amount: $5M
Latest Entry Price: $0.022 with a 1:2 AVEO
Today’s Price Change: $0.008 -11.11%
Sector: Medicinal Cannabis
Deal Type: Placement
Raise Amount: $6.6M
Latest Entry Price: $0.033 with 1:2 ECSO
Today’s Price Change: $0.02 Unchanged
If you would like more information on future Peak deals, please don’t hesitate to get in touch.
Peak accepts no responsibility for any views expressed and marketing material contained in this email except where the message specifically states otherwise and the sender is authorised to state them to be the views of Peak. Information provided in this email is general advise only and does take account your objectives, financial situation or needs. Before acting on any advice in this email, Peak recommends that you consider whether it is appropriate for your circumstances. If this email contains reference to any financial products, you should obtain the current Product Disclosure Statement (PDS) or other disclosure documents for the particular products and consider this information before making any decisions regarding the products. The Financial Services Guide (FSG) can be found at www.peakassetmanagement.com.au or by telephoning Peak on 1300 304 460
